Literature DB >> 8459224

Site-specific deletions involving the tal-1 and sil genes are restricted to cells of the T cell receptor alpha/beta lineage: T cell receptor delta gene deletion mechanism affects multiple genes.

T M Breit1, E J Mol, I L Wolvers-Tettero, W D Ludwig, E R van Wering, J J van Dongen.   

Abstract

Site-specific deletions in the tal-1 gene are reported to occur in 12-26% of T cell acute lymphoblastic leukemias (T-ALL). So far two main types of tal-1 deletions have been described. Upon analysis of 134 T-ALL we have found two new types of tal-1 deletions. These four types of deletions juxtapose the 5' part of the tal-1 gene to the sil gene promoter, thereby deleting all coding sil exons but leaving the coding tal-1 exons undamaged. The recombination signal sequences (RSS) and fusion regions of the tal-1 deletion breakpoints strongly resemble the RSS and junctional regions of immunoglobulin/T cell receptor (TCR) gene rearrangements, which implies that they are probably caused by the same V(D)J recombinase complex. Analysis of the 134 T-ALL suggested that the occurrence of tal-1 deletions is associated with the CD3 phenotype, because no tal-1 deletions were found in 25 TCR-gamma/delta + T-ALL, whereas 8 of the 69 CD3- T-ALL and 11 of the 40 TCR-alpha/beta + T-ALL contained such a deletion. Careful examination of all TCR genes revealed that tal-1 deletions exclusively occurred in CD3- or CD3+ T-ALL of the alpha/beta lineage with a frequency of 18% in T-ALL with one deleted TCR-delta allele, and a frequency of 34% in T-ALL with TCR-delta gene deletions on both alleles. Therefore, we conclude that alpha/beta lineage commitment of the T-ALL and especially the extent of TCR-delta gene deletions determines the chance of a tal-1 deletion. This suggests that tal-1 deletions are mediated via the same deletion mechanism as TCR-delta gene deletions.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8459224      PMCID: PMC2190963          DOI: 10.1084/jem.177.4.965

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  44 in total

Review 1.  Receptor diversity of human T-cell receptor gamma delta expressing cells.

Authors:  T M Breit; I L Wolvers-Tettero; J J van Dongen
Journal:  Prog Histochem Cytochem       Date:  1992

2.  Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage.

Authors:  E A Macintyre; L Smit; J Ritz; I R Kirsch; J L Strominger
Journal:  Blood       Date:  1992-09-15       Impact factor: 22.113

3.  Enhancer-binding activity of the tal-1 oncoprotein in association with the E47/E12 helix-loop-helix proteins.

Authors:  H L Hsu; J T Cheng; Q Chen; R Baer
Journal:  Mol Cell Biol       Date:  1991-06       Impact factor: 4.272

Review 4.  V(D)J recombination: molecular biology and regulation.

Authors:  D G Schatz; M A Oettinger; M S Schlissel
Journal:  Annu Rev Immunol       Date:  1992       Impact factor: 28.527

Review 5.  Helix-loop-helix genes translocated in lymphoid leukemia.

Authors:  J Visvader; C G Begley
Journal:  Trends Biochem Sci       Date:  1991-09       Impact factor: 13.807

Review 6.  Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects.

Authors:  J J van Dongen; I L Wolvers-Tettero
Journal:  Clin Chim Acta       Date:  1991-04       Impact factor: 3.786

7.  SCL is coexpressed with GATA-1 in hemopoietic cells but is also expressed in developing brain.

Authors:  A R Green; T Lints; J Visvader; R Harvey; C G Begley
Journal:  Oncogene       Date:  1992-04       Impact factor: 9.867

8.  Structural characterization of SIL, a gene frequently disrupted in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; I R Kirsch
Journal:  Mol Cell Biol       Date:  1991-11       Impact factor: 4.272

9.  V(D)J recombinase-like activity mediates hprt gene deletion in human fetal T-lymphocytes.

Authors:  J C Fuscoe; L J Zimmerman; M J Lippert; J A Nicklas; J P O'Neill; R J Albertini
Journal:  Cancer Res       Date:  1991-11-01       Impact factor: 12.701

10.  Involvement of the putative hematopoietic transcription factor SCL in T-cell acute lymphoblastic leukemia.

Authors:  P D Aplan; D P Lombardi; G H Reaman; H N Sather; G D Hammond; I R Kirsch
Journal:  Blood       Date:  1992-03-01       Impact factor: 22.113

View more
  22 in total

1.  The study of minimal residual disease in acute lymphoblastic leukaemia.

Authors:  C J Knechtli; N J Goulden; K Langlands; M N Potter
Journal:  Clin Mol Pathol       Date:  1995-04

2.  Gender-specific frequency of background somatic mutations at the hypoxanthine phosphoribosyltransferase locus in cord blood T lymphocytes from preterm newborns.

Authors:  M Yoshioka; P M Vacek; T Poseno; R Silver; B A Finette
Journal:  Proc Natl Acad Sci U S A       Date:  1999-01-19       Impact factor: 11.205

3.  Oncogene regulation. An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element.

Authors:  Marc R Mansour; Brian J Abraham; Lars Anders; Alla Berezovskaya; Alejandro Gutierrez; Adam D Durbin; Julia Etchin; Lee Lawton; Stephen E Sallan; Lewis B Silverman; Mignon L Loh; Stephen P Hunger; Takaomi Sanda; Richard A Young; A Thomas Look
Journal:  Science       Date:  2014-11-13       Impact factor: 47.728

4.  V(D)J recombinase-mediated processing of coding junctions at cryptic recombination signal sequences in peripheral T cells during human development.

Authors:  Janet M Murray; J Patrick O'Neill; Terri Messier; Jami Rivers; Vernon E Walker; Brien McGonagle; Lucy Trombley; Lindsay G Cowell; Garnett Kelsoe; Fraser McBlane; Barry A Finette
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

5.  In vivo transposition mediated by V(D)J recombinase in human T lymphocytes.

Authors:  Terri L Messier; J Patrick O'Neill; Sai-Mei Hou; Janice A Nicklas; Barry A Finette
Journal:  EMBO J       Date:  2003-03-17       Impact factor: 11.598

6.  Rearrangements of the human TCRD-deleting elements.

Authors:  T M Breit; I L Wolvers-Tettero; A J Bogers; R R de Krijger; J W Wladimiroff; J J van Dongen
Journal:  Immunogenetics       Date:  1994       Impact factor: 2.846

Review 7.  Genomic Alterations of Non-Coding Regions Underlie Human Cancer: Lessons from T-ALL.

Authors:  Adrian Rivera-Reyes; Katharina E Hayer; Craig H Bassing
Journal:  Trends Mol Med       Date:  2016-10-27       Impact factor: 11.951

Review 8.  Role of non-coding sequence variants in cancer.

Authors:  Ekta Khurana; Yao Fu; Dimple Chakravarty; Francesca Demichelis; Mark A Rubin; Mark Gerstein
Journal:  Nat Rev Genet       Date:  2016-01-19       Impact factor: 53.242

Review 9.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

10.  Cryptic signals and the fidelity of V(D)J joining.

Authors:  S M Lewis; E Agard; S Suh; L Czyzyk
Journal:  Mol Cell Biol       Date:  1997-06       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.